The latest data on hedge funds’ prime-broker relationships show most of the big Wall Street banks are losing market share while a number of smaller...Read more.
A likely sticking point in Och-Ziff Capital’s settlement talks with the U.S. Justice Department is the applicability of the “bad-actor”...Read more.
Passport Capital’s funds again diverged from industry averages in March, this time by posting losses amid gains in the broader market.Read more.
A financial-technology startup is offering investors direct access to distressed debt, liquidations and other complex deals for minimum investments of just...Read more.
Pershing Square Capital’s investment in troubled Valeant Pharmaceuticals has left its funds so far below their high-water marks that it will likely...Read more.
Balyasny Asset Management has stopped accepting contributions to one of its two main funds.Read more.
Equity-focused hedge fund managers are bracing for redemptions from sovereign wealth funds in the Middle East.Read more.
A Crestline Investors team that trades distressed hedge fund shares and assets on the secondary market has moved to startup Jupiter Peak Capital.Read more.
It turns out that the SEC’s investigation of Eden Arc Capital centers on the firm’s recruitment of terminally ill people for the purpose of...Read more.
Warwick Capital is struggling to unwind a European distressed-asset fund.Read more.
(SEE UPDATE BELOW) Wells Fargo is in talks to buy what could amount to a major portion of Credit Suisse’s investment-banking and capital-markets...Read more.